Chemical Warfare Agent Contract With US/UK Special Operations

US $100 Million of Testing In 2017

Sponsored
AGORACOM NEWS FLASH

BREAKING NEWS!!!

TetraBio-Pharma Receives Approval to List on the TSX Venture Exchange

Tbp large new

  • Bernard Fortier, CEO of Tetra Bio-Pharma Inc. stated “... We look forward to aggressively executing our business plan as we build the leading bio-pharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs.”

Hub On AGORACOM/ Corporate Profile / Read Release

Message: FEATURE: PyroGenesis $PYR.ca Clients include: U.S Air Force, U.S NAVY, Canada Natural Resources

 

PYR: TSX-V

WHY PYROGENESIS?

  • 2016 Revenues of $5.2M
  • Increased Gross margins to 41.6% (2015: 27.1%)
  • Traditional lines of business are poised to contribute significantly to bottom line
  • Established backlog of signed contracts, majority of which are expected to be completed in 2017   
  • Clients include: U.S Air Force, U.S NAVY, Canada Natural Resources

12 Month Stock Chart:

 

Share
New Message
Please login to post a reply